Pilot Study to Prevent Early-Onset Group B Streptococcal Disease in Newborns

Advances in Neonatal Care

Volumn 6, Issue 4, 2006, Pages 208-219

  Jefferson, Urmeka Taylor ^a  

^a UNIVERSITY OF MEMPHIS   (United States)

Author keywords

compliance; early onset GBS disease; GBS practice guidelines; infection; intrapartum antibiotic prophylaxis; neonatal sepsis; newborn; prevention

Indexed keywords

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHI SQUARE DISTRIBUTION; DISEASE TRANSMISSION; FEMALE; HUMAN; NEWBORN; PILOT STUDY; PREGNANCY; PREGNANCY COMPLICATION; RETROSPECTIVE STUDY; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VERTICAL TRANSMISSION;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; CHI-SQUARE DISTRIBUTION; DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PILOT PROJECTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 33746694775     PISSN: 15360903     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.adnc.2006.04.006     Document Type: Article

References (32)

1. Hager W.D., Schuchat A., Gibbs R., Sweet R., Mead P., et al. Prevention of perinatal group B streptococcal infection. current controversies. Obstet Gynecol 96 (2000) 141-145
2. Centers for Disease Control and Prevention, Division of Bacterial and Mycotic Diseases. Group B Streptococcal Disease. Available at: http://www.cdc.gov/ncidod/dbmd/diseaseinfo/groupbstrep_g.htm. Accessed October 27, 2002.
3. James D.C. Maternal screening and treatment for group B streptococcus. J Obstet Gynecol Neonatal Nurs 30 (2001) 659-666
4. Dermer P., Lee C., Eggert J., and Few B. A history of neonatal group B streptococcus with its related morbidity and mortality rates in the United States. J Pediatr Nurs 19 (2004) 357-363
5. Schrag S., Gorwitz R., Fultz-Butts K., and Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 51 (2002) 1-22
6. McDuffie RS Jr. OB/GYN infection: screening techniques for group B streptococcal infection. Contemporary Ob/Gyn 2000;12:105-116. Available at: http://www.contemporaryobgyn.net/obgyn/article/articleDetail.jsp?id=1396 72 . Accessed April 6, 2006.
7. Chandran L., Navaie-Waliser M., Zulqarni N.J., Batra S., Bayir H., et al. Compliance with group B streptococcal disease prevention guidelines. MCN Am J Matern Child Nurs 26 (2001) 313-319
8. Mitchell A., Steffenson N., Hogan H., and Brooks S. Neonatal group B streptococcal disease. MCN Am J Matern Child Nurs 22 (1997) 249-253
9. Hickman M.E., Rench M.A., Ferrieri P., and Baker C.J. Changing epidemiology of group B streptococcal colonization. Pediatrics 104 (1999) 203-209
10. Ramus R.M., McIntire D.D., and Wendel Jr. G.D. Antibiotic chemoprophylaxis for group B strep is not necessary with elective cesarean section at term [abstract]. Am J Obstet Gynecol 180 (1999) S85
11. Glezen W.P. Maternal vaccines. Prim Care 28 (2001) 791-806
12. Mullaney D.M. Group B streptococcal infections in newborns. J Obstet Gynecol Neonatal Nurs 30 (2001) 649-658
13. deCueto M., Sanchez M.J., Sampedro A., Miranda J.A., Herruzo A.J., et al. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol 91 (1998) 112-114
14. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics 90 (1992) 775-778
15. Group B streptococcal infections in pregnancy. ACOG Technical Bulletin Number 170-July 1992. Int J Gynaecol Obstet 42 (1993) 55-59
16. Glantz J.C., and Kedley K.E. Concepts and controversies in the management of group B streptococcus during pregnancy. Birth 25 (1998) 45-53
17. Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep. 1996;45:1-24. Erratum in: MMWR Morb Mortal Wkly Rep. 1996;45:679.
18. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics. 1997;99:489-496. Available at: http://pediatrics.aappublications.org/cgi/content/full/99/3/489. Accessed January 26, 2006.
19. Glasgow T.S., Young P.C., Wallin J., Kwok C., Stoddard G., et al. Association of intrapartum antibiotic exposure and late-onset serious bacterial infections in infants. Pediatrics 116; (2005) 696-702
20. Schrag S.J., Zywicki S., Farley M.M., Reingold A.L., Harrison L.H., et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342 (2000) 15-20
21. Schelonka R.L., Freij B.J., and McCracken Jr. G.H. Bacterial and fungal infections. In: MacDonald M.G., Seshia M.M., and Mullett M.D. (Eds). Avery's Neonatology: Pathophysiology and Management of the Newborn. 6th ed. (2005), Lippincott Williams & Wilkins, Philadelphia, Pa 1238-1240
22. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 347 (2002) 240-247
23. Lopez Sastre J.B., Fernandez Colomer B., Coto Cotallo G.D., Ramos Aparicio A., and Grupo de Hospitales Castrillo. Trends in the epidemiology of neonatal sepsis of vertical transmission in the era of group B streptococcal prevention. Acta Paediatr 94 (2005) 451-457
24. Yancey M.K., Schuchat A., Brown L.K., Ventura V.L., and Markenson G.R. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 88 (1996) 811-815
25. Gilson G.J., Christensen F., Romero H., Bekes K., Silva L., et al. Prevention of Group B streptococcus early-onset neonatal sepsis. comparison of the Centers for Disease Control and prevention screening-based protocol to a risk-based protocol in infants at greater than 37 weeks' gestation. J Perinatol 20 (2000) 491-495
26. U.S. Food and Drug Administration, Center for Devices and Radiological Health. FDA Safety Alert: Risks of Devices for Direct Detection of Group B Streptococcal Antigen. Available at: http://www.fda.gov/cdrh/gbstrep.html . Accessed December 13, 2005.
27. Turner M.A., Power S., and Emmerson A.J. Gestational age and the C-reactive protein response. Arch Dis Child Fetal Neonatal Ed 89; (2004) F272-F273
28. Franz A.R., Bauer K., Schalk A., Garland S.M., Bowman E.D., et al., International IL-8 Study Group. Measurement of interleukin 8 in combination with C-reactive protein reduced unnecessary antibiotic therapy in newborn infants. a multicenter, randomized, controlled trial. Pediatrics 114 (2004) 1-8 Erratum in: Pediatrics. 2004;114:1746
29. Manucha V., Rusia U., Sikka M., Faridi M.M., and Madan N. Utility of hematological parameters and C-reactive protein in the detection of neonatal sepsis. J Paediatr Child Health 38 (2002) 459-464
30. Handbook of Diagnostic Tests. 3rd ed. (2003), Lippincott Williams & Wilkins, Philadelphia, Pa 152
31. Puopolo K.M. Bacterial and fungal Infections. In: Cloherty J.P., Stark A., and Eichenwald E.C. (Eds). Manual of Neonatal Care. 5th ed. (2004), Lippincott Williams & Wilkins, Philadelphia, Pa 292
32. Polit D., and Hungler B.P. In: Polit D., and Hungler B.P. (Eds). Nursing Research. Principles and Methods. 6th ed. (1999), Lippincott Williams & Wilkins, Philadelphia, Pa 175-215